• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Genzyme

Genzyme

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Sanofi Genzyme Announces Recipients of 2016 Patient Advocacy Leadership (PAL) Awards

    Sanofi Genzyme Announces Recipients of 2016 Patient Advocacy Leadership (PAL) Awards

  2. $85.4 Billion Monoclonal Antibodies (mAbs) Market Analysis By Source, By Type of Production, By Indication, By End-use And Segment Forecasts, 2013 - 2024 - Research and Markets

    $85.4 Billion Monoclonal Antibodies (mAbs) Market Analysis By Source, By Type of Production, By Indication, By End-use And Segment Forecasts, 2013 - 2024 - Research and Markets

  3. Sanofi and Boehringer Ingelheim Confirm Closing of Business Swap on January 1st 2017

    Sanofi and Boehringer Ingelheim Confirm Closing of Business Swap on January 1st 2017

  4. Pompe Disease Treatment – Market Drivers and Forecasts by Technavio

    Pompe Disease Treatment – Market Drivers and Forecasts by Technavio

  5. REITs, Target Dates, Dollar-Proofing, and More

    A roundup of investment news.

  6. High-Confidence Stock Picks

    Focusing on stocks with the most visible cash flows has been a winning strategy, and this screen can find them.

  7. Back to Basics

    This screen finds stocks that would make it into Morningstar's Wide-Moat Focus strategy.

  8. Early Favorites for Manager of the Year--Domestic Stock

    Who's in front heading 'round the bend?

  9. Pharmaceutical Firms Get the Urge to Merge

    Morningstar analysts see pharmaceuticals as 2010's hot zone for mergers and acquisitions.

123
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.